InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms. The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.
Часто задаваемые вопросы
В каком секторе работает InnoCan Pharma Corporation (INNPF)?
InnoCan Pharma Corporation относится к сектору Здравоохранение.
Какова текущая цена акций InnoCan Pharma Corporation (INNPF)?
По последним данным, цена акций InnoCan Pharma Corporation составляет 1,29 $, предыдущее закрытие — 1,29 $.
Выплачивает ли InnoCan Pharma Corporation (INNPF) дивиденды?
Нет, InnoCan Pharma Corporation не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у InnoCan Pharma Corporation (INNPF)?
У компании InnoCan Pharma Corporation бета -0.257, что указывает на более низкую волатильность по сравнению с рынком в целом.
